BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, April 12, 2026
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
The alpha1L-adrenoceptor: a new target for BPH therapy
April 6, 1998
American Home Products synthesizes and evaluates new smooth muscle relaxants
April 6, 1998
Takeda claims bicyclic compounds for micturition disorders
April 6, 1998
Dual-action agent for BPH developed at Zeria
April 3, 1998
N-Alkylated saccharins from Merck & Co. with potential in BPH therapy
April 2, 1998
FDA approves DDAVP tablets for nocturnal enuresis in children
April 1, 1998
New vasopressin antagonist from JT with aquaretic effects in animals
April 1, 1998
Detrol approved by FDA for overactive bladder
March 30, 1998
Synaptic licenses technology for BPH treatment to Glaxo Wellcome
March 25, 1998
Genetic basis for congenital kidney disease pinpointed by BioStratum scientists
March 23, 1998
Previous
1
2
…
310
311
312
313
314
315
316
317
318
…
337
338
Next